Park Place Capital Corp »

Agios Pharmaceuticals shares owned by Park Place Capital Corp

Quarter-by-quarter ownership of Agios Pharmaceuticals (AGIO) shares owned by Park Place Capital Corp from 13F filings

Historical chart of Park Place Capital Corp investment in Agios Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Agios Pharmaceuticals held by Park Place Capital Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Agios Pharmaceuticals by Park Place Capital Corp

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.1k 72 29.24

More positions owned by Park Place Capital Corp

Ishares Core S&p 500 Etf Etf (IVV)
Microsoft Corp Stock (MSFT)
Ishares Core Msci Eafe Etf Etf (IEFA)
Ishares Core S&p Small Cap Etf Etf (IJR)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Ishares S&p 500 Growth Etf Etf (IVW)
Aptus Defined Risk Etf Etf (DRSK)
Ishares S&p 500 Value Etf Etf (IVE)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Aptus Collared Investment Opportunity Etf Etf (ACIO)
Apple Stock (AAPL)
Ishares Mbs Etf Etf (MBB)
Ishares Russell 1000 Growth Etf Etf (IWF)
Amazon Stock (AMZN)
Schwab U.s. Large-cap Growth Etf Etf (SCHG)

View all positions for Park Place Capital Corp

Top funds holding Agios Pharmaceuticals

Vanguard Group
Bellevue Group
Dimensional Fund Advisors
Jpmorgan Chase & Co
T. Rowe Price Associates
Arrowpoint Asset Management
Citadel Advisors
Bnp Paribas Investment Partners
Fisher Investments
Goldman Sachs Group
Deutsche Bank Aktiengesellschaft
Frazier Life Sciences Management
Hudson Bay Capital Management
Charles Schwab Investment Management
Assenagon Asset Management

View all funds holding Agios Pharmaceuticals